Scilex Holding Company Company Profile
NASDAQ: SCLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.96-0.53 (-15.19%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Scilex at a glance
Scilex Holding Company (NASDAQ: SCLX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Palo Alto, CA. The company's shares have traded publicly since 2021. At a market capitalization of $20.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001820190, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Scilex Holding Company
- Ticker
- NASDAQ: SCLX
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- 960 San Antonio Road 94303, Palo Alto, CA, United States
- Phone
- (650) 516-4310
- IPO year
- 2021
- Market cap
- $20.82M
- SEC CIK
- 0001820190
- Latest annual report
- 10-K · Apr 10, 2026
Companies similar to Scilex
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| JSPRJasper Therapeutics Inc. | 0.56 | -1.70% | $18.63M | vs SCLX |
| ESLAEstrella Immunopharma Inc. | 0.4175 | -0.43% | $18.16M | vs SCLX |
| DYAIDyadic International Inc. | 0.4444 | -2.65% | $17.80M | vs SCLX |
| ATYRaTyr Pharma Inc. | 0.2553 | -8.26% | $25.04M | vs SCLX |
| BCDABioCardia Inc. | 1.06 | -2.75% | $16.05M | vs SCLX |
| TCRXTScan Therapeutics Inc. | 0.2282 | -17.59% | $15.47M | vs SCLX |
| EVAXEvaxion A/S ADR | 3.05 | -2.87% | $27.52M | vs SCLX |
| INABIN8bio Inc. | 1.38 | -1.43% | $13.60M | vs SCLX |